"A patent is a type of property right. It gives the
patent holder the right, for a limited time, to exclude others from
making, using, offering to sell, selling, or importing into the United
States the subject matter that is within the scope of protection granted
by the patent." - U.S. Patent Office

i-BPE
is an open gene patent machine.
i-BPE will raid trans-corporate bio-pirate silos.
i-BPE agents will offer trans-corporate DNA play, for non-governmental
ownership.
i-BPE will filter the gene market's esoteric intelligence networks for
aggressive take-over by i-BPE agents.
i-BPE gene patents will return bio-rights to non-governmental, cultural
agents for revision.
i-BPE is an open gene project. i-BPE is a counter-market-objectivity
tool.
i-BPE is a patent the patent action.

Why
do we need an i-Biology Patent Engine (i-BPE)?

Against the backdrop of the
September 11th terrorist attacks in the US, the anthrax crisis has raised
highly controversial issues related to intellectual property rights. By
waiving the Bayer patent, the US would be able to approach other companies
to manufacture greater and cheaper supplies of ciprofloxacin, as the drug
is known generically. This would ease concerns that Bayer might not be
able to produce enough ciprofloxacin to counter widespread anthrax attacks.
However, any move to override the Bayer patent would represent a serious
policy U-turn for the Bush administration, which the administration is
unwilling to do. For them profit is more important then public health.
Just last year, the world witnessed heated debate on the patent controversy
when the Pharmaceutical Manufacturers' Association of South Africa (a
WTO member) took the South African government to court to prevent it from
importing cheaper versions of patented AIDS drugs. Under tremendous pressure
from health activists around the world, the drug companies and WTO unconditionally
dropped their lawsuit against the South African government. How will the
i-Biology Patent Engine function (i-BPE)? The i-Biology Patent Engine
(i-BPE) will allow on-line communities to revise and archive new patents.
(i-BPE) software opens the source of current trans-corporate patents,
by offering users the means to assemble their own inventions by recycling
existing ones. The real patents and the i-BPE patents will be placed in
a data repository and offered to the end users for further remixing. The
i-Biology Patent Engine (i-BPE) can then be downloaded as a file. The
file will be designed to mimic existing patent forms. A few choice biotech
patents targeted for remixing: